Correspondence from bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies, Inc.
Date: June 12, 2026 · CIK: 0001712762 · Accession: 0001493152-26-028534

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-296764

Date

June 12, 2026

Author

Chief

Form

CORRESP

Company

bioAffinity Technologies, Inc.

Letter

bioAffinity Technologies, Inc.

Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(210) 698-5334

June 12, 2026

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Nicholas O’Leary

Re: bioAffinity Technologies, Inc.

Registration Statement on Form S-1

Filed June 12, 2026

File No. 333-296764

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), bioAffinity Technologies, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, June 16, 2026, or as soon thereafter as possible.

Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Very
truly yours,
BIOAFFINITY
TECHNOLOGIES, INC.

Show Raw Text

CORRESP
1
filename1.htm

bioAffinity
Technologies, Inc.

3300
Nacogdoches Road, Suite 216

San
Antonio, Texas 78217

(210)
698-5334

June
12, 2026

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Nicholas O’Leary

    Re:
    bioAffinity
    Technologies, Inc.

    Registration Statement on Form S-1

    Filed
    June 12, 2026

    File
    No. 333-296764

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), bioAffinity Technologies,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, June 16, 2026, or as soon thereafter as possible.

Please
notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Very
    truly yours,

    BIOAFFINITY
    TECHNOLOGIES, INC.

    By:
    /s/
    Maria Zannes

    Name:
    Maria
    Zannes

    Title:
    Chief
    Executive Officer

SecProbe.io